TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Norwegian Pharma AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,032
|
1,143
|
1,509 |
| Financial expenses |
4
|
5
|
11 |
| Earnings before taxes |
192
|
237
|
462 |
| Total assets |
654
|
908
|
1,272 |
| Current assets |
654
|
908
|
1,272 |
| Current liabilities |
172
|
156
|
164 |
| Equity capital |
482
|
752
|
1,108 |
| - share capital |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
73.7%
|
82.8%
|
87.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
18.6%
|
20.7%
|
30.6% |
| Return on assets (ROA) |
30.0%
|
26.7%
|
37.2% |
| Current ratio |
380.2%
|
582.1%
|
775.6% |
| Return on equity (ROE) |
39.8%
|
31.5%
|
41.7% |
| Change turnover |
-51
|
-449
|
27 |
| Change turnover % |
-5%
|
-28%
|
2% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.